Finally, EC activation—dysfunction and eNOS uncoupling with decreased bioavailable NO are extremely important to the development and progression of the MetS reloaded and its increased risk for the development of CCVD and T2DM (Figure 1) [12,14]. The gene discussed is NOS3; the disease is metabolic syndrome.